Yuji Uehara, Medical Oncologist at National Cancer Center Hospital, Data Analyst and Researcher at UC San Diego Health, shared a post on X:
“Excited to share our editorial with Hiroto Hatano in Lung Cancer. We discuss GPC1-directed ADCs as a potential new therapeutic approach for lung squamous cell carcinoma. Encouraging preclinical data, with key translational questions ahead.”
Title: A new surface to target: Glypican-1-directed ADCs in lung squamous cell carcinoma
Authors: Hiroto Hatano, Yuji Uehara
Read the Full Article.
Other articles featuring Yuji Uehara on Oncodaily.